1. [Virus-induced dyslipidemias as possible risk factors in the development of somatic diseases]
- Author
-
T V, Amvros'eva, V I, Votiakov, S V, Orlova, V G, Gudkov, A S, Virinskaia, Iu G, Il'kevich, M P, Samarina, and N P, Mishaeva
- Subjects
Adult ,Male ,Time Factors ,Lipoproteins ,Guinea Pigs ,Drug Evaluation, Preclinical ,Hyperlipidemias ,Hepatitis A ,Combined Modality Therapy ,Lipids ,Rotavirus Infections ,Lincomycin ,Prion Diseases ,Disease Models, Animal ,Mice ,Risk Factors ,Animals ,Humans ,Female ,Rabbits ,Encephalitis, Tick-Borne - Abstract
Experimental and clinical studies showed a number of virus infections to be accompanied by lipidemic disorders. Experimentally, dyslipidemias were found in tick-borne encephalitis (TBE) in mice, rotavirus infection in rabbits, and amyotrophic leukospongiosis in guinea pigs. The possibility of correcting the virus-induced lipidemic disorders with an antiviral drug, lincomycin, was demonstrated in TBE in mice. Dynamic study of the lipidemic status of patients with virus hepatitis A revealed marked dyslipidemia of the atherogenic type which was stable and persisted up to the time of clinical recovery. The data obtained supplement the current concepts concerning the pathogenesis of virus infections.
- Published
- 1994